Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction



Status:Active, not recruiting
Conditions:Other Indications, Blood Cancer
Therapuetic Areas:Oncology, Other
Healthy:No
Age Range:18 - 99
Updated:9/27/2018
Start Date:August 22, 2017
End Date:April 1, 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

The Role of Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction Chemotherapy

This is an observational study to collect stool, blood, and urine from acute leukemia
patients undergoing induction chemotherapy in order to generate preliminary data regarding
the association between microbiota and chemotherapy-induced gut barrier damage. This study
consists of inpatient collections of blood, urine, and stool while the patients are
undergoing inpatient induction therapy. Patients will not be scheduled for any additional
procedures or testing beyond what is required for clinical care.


Inclusion Criteria:

- Adults (ages 18 - 99 years) undergoing inpatient induction chemotherapy for newly
diagnosed or relapsed acute leukemia (myeloid or lymphoblastic).

- Any induction regimen (standard or experimental) with planned ~4 weeks of inpatient
stay

- Able to provide written voluntary consent before performance of any study related
procedure.
We found this trial at
1
site
Masonic Cancer Center at University of Minnesota
425 E River Pkwy # 754
Minneapolis, Minnesota 55455
612-624-2620
Phone: 612-625-9604
Masonic Cancer Center at University of Minnesota The Masonic Cancer Center was founded in 1991....
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials